| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SAGE THERAPEUTICS | 9,773,073 | 490,901,000 | 52.36% | ||
| 2 | FOUNDATION MEDICINE INC COM | 4,927,234 | 237,049,000 | 25.28% | ||
| 3 | ZAFGEN INC COM | 4,202,045 | 166,443,000 | 17.75% | ||
| 4 | ELEVEN BIOTHERAPEUTICS INC | 4,841,591 | 43,187,000 | 4.61% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001012975-15-000311, filed 2015.04.29).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
